# Considerations for Allogeneic Pancreatic Islet Cell Products:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/considerations-for-allogeneic-pancreatic-islet-cell-products-guidance-for-industry/6b1f2a33-5292-47b8-8e57-b821eba6fa0b

> FDA guidance document: Considerations for Allogeneic Pancreatic Islet Cell Products:  Guidance for Industry. Issue date: September 01, 2009. Get complete insights and analysis.

---

## Details

- Title: Considerations for Allogeneic Pancreatic Islet Cell Products:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Biologics Evaluation and Research
- Office URL: /offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
- Issue Date: 2009-09-01
- Last Changed: 2019-05-16
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2008-D-0293">FDA-2008-D-0293</a>

## Related Documents

- [Clinical Considerations for Therapeutic Cancer Vaccines:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/clinical-considerations-for-therapeutic-cancer-vaccines-guidance-for-industry/e0e6e4e0-a883-4f71-bf37-784e147d32d9)
- [Preclinical Assessment of Investigational Cellular and Gene Therapy Products:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/preclinical-assessment-of-investigational-cellular-and-gene-therapy-products-guidance-for-industry/e4aedc4e-81e3-4d2e-b655-2460ccf3a04e)
- [Nucleic Acid Testing  to Reduce the Possible Risk of Parvovirus B19 Transmission by Plasma-Derived Products:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/nucleic-acid-testing-to-reduce-the-possible-risk-of-parvovirus-b19-transmission-by-plasma-derived-products-guidance-for-industry/61270a0b-4323-4d9d-8dab-c2b9ea3aaf2c)